# Acadia Pharmaceuticals Inc: Form 8-K, filed Nov 6, 2024

- Company: [Acadia Pharmaceuticals Inc](/companies/acad.md) (CIK 1070494)
- Form: 8-K
- Filed: 2024-11-06
- Accepted by EDGAR: Nov 6, 2024, 16:14 ET
- Period: 2024-11-06
- Accession: 0000950170-24-122322
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1070494/000095017024122322/acad-20241106.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1070494/000095017024122322/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1070494/000095017024122322/acad-20241106.htm

Filed Nov 6, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-122322. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.